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http://dx.doi.org/10.1016/j.ccr.2013.08.012SUMMARYRecently extravasated metastatic cancer cells use the Rif/mDia2 actin-nucleating/polymerizing machinery in
order to extend integrin b1-containing, filopodium-like protrusions (FLPs), which enable them to interact pro-
ductively with the surrounding extracellular matrix; this process governs the initial proliferation of these
cancer cells. Here, we identify the signaling pathway governing FLP lifetime, which involves integrin-linked
kinase (ILK) and b-parvin, two integrin:actin-bridging proteins that block cofilin-mediated actin-filament
severing. Notably, the combined actions of Rif/mDia2 and ILK/b-parvin/cofilin pathways on FLPs are
required not only for metastatic outgrowth but also for primary tumor formation following experimental
implantation. This provides one mechanistic explanation for how the epithelial-mesenchymal transition
(EMT) program imparts tumor-initiating powers to carcinoma cells, since it enhances FLP formation through
the activation of ILK/b-parvin/cofilin pathway.INTRODUCTION
The greatmajority of disseminated cancer cells fail to survive and
proliferate after landing in a foreign tissue (Chambers et al.,
2002). This explains why only a small minority of disseminated
cancer cells succeeds, via the process of colonization, in gener-
ating the macroscopic metastases that are responsible for more
than 90% of cancer-associated deaths (Fidler, 2003). This
highlights the need to elucidate the mechanisms that allow
metastasized cells to survive and proliferate after settling in the
parenchyma of foreign tissues.
We and others previously studied a set of three mouse mam-
mary carcinoma cell lines—D2.0R, D2.1, and D2A1 (hereinafter
collectively referred to as D2 cells)—with differing metastatic
potentials (Barkan et al., 2008; Shibue and Weinberg, 2009).
Thus, after being introduced into mice via the tail vein, these
three cell populations extravasate into the lung parenchymaSignificance
The proliferation of recently extravasated metastatic cancer c
their ability to establish integrin-mediated adhesions with the e
The formation of these adhesions is enabled by the extension
turn, is encouraged by the epithelial-mesenchymal transition
proliferation of both recently extravasated metastatic carcinom
dynamics help to explain how the EMT program can increase th
is used experimentally to define cancer stem cells.
Cwith equal efficiency and exhibit comparable rates of initial
survival; however, while the colonization-competent D2A1 cells
subsequently proliferate rapidly, the colonization-deficient
D2.0R and D2.1 cells fail to do so (see Figure S1A available
online). Hence, these three D2 cell populations provide a model
system to study the mechanisms governing the proliferation of
recently extravasated cancer cells in the lung parenchyma.
These studies led us to discover that focal adhesion kinase
(FAK) signaling governs the postextravasation proliferation of
the aggressive D2A1 cells in the lungs, doing so by controlling
the activity of the extracellular-signal regulated kinases (ERKs)
(Shibue andWeinberg, 2009; Shibue et al., 2012). FAK activation
in these D2A1 cells appeared to depend, in turn, on the interac-
tions of these cells with components of the extracellular matrix
(ECM) in the lung parenchyma, which are mediated specifically
by the formation of elongated, integrin b1-containing adhesion
plaques.We found that the development of such plaques requireells and experimentally implanted cancer cells depends on
xtracellular matrix of the tissues that they initially encounter.
of filopodium-like protrusions (FLPs), whose formation, in
(EMT) program. In this fashion, the EMT program facilitates
a cells and those that are experimentally implanted. These
e tumor-initiating potential of carcinoma cells—the trait that
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Figure 1. b-Parvin as a Key Regulator of FLP Formation
(A) Kinetics of FLP assembly and disassembly. The periods of FLP persistence (top left) and the rate of de novo FLP formation (bottom left) were plotted.
Three different D2 cell populations (expressing an actin marker lifeact-YPet) were analyzed by time-lapse microscopy (right). The appearance of new
FLPs and the retraction of previously present FLPs are marked by blue and open white arrowheads, respectively. (*), p < 0.002 by log-rank test versus D2A1.
(ns), p > 0.1.
(B and C) mRNA (B) and protein (C) expression for various integrin-actin linkers.
(legend continued on next page)
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Cancer Cell
An Integrin-Actin Link Enabling Tumor Initiationthe prior assembly of integrin b1-containing, filopodium-like pro-
trusions (FLPs)—actin-rich protrusions morphologically resem-
bling filopodia formed by cells growing in monolayer culture. In
contrast, the slowly proliferating D2.0R and D2.1 cells develop
very few FLPs and elongated adhesion plaques in the lung
parenchyma and display low levels of FAK and ERK activation
(Shibue et al., 2012; Figure S1A).
By testing various breast cancer cell lines that exhibit differing
metastatic powers in mice, we also found that a diverse array of
colonization-competent cells assemble such FLPs in far greater
numbers than do their colonization-deficient counterparts (Shi-
bue et al., 2012). This suggested that the ability to extend abun-
dant FLPs critically determines the competence of these breast
cancer cells to colonize foreign tissues. In the present study, we
undertook to identify the key regulators of FLP formation, with
the anticipation that these regulators also serve as molecular
determinants of colonization competence.
RESULTS
Differing Expression Levels of b-Parvin in Colonization-
Competent and -Deficient Cells
In an attempt to elucidate the mechanism(s) governing FLP for-
mation, we exploited a three-dimensional (3D) culture model,
termed ‘‘Matrigel on-top’’ (MoT), in which cells are plated above
a layer of 100% Matrigel and then covered with culture medium
containing 2%Matrigel (Debnath et al., 2003). When propagated
in this MoT model, the aggressive D2A1 cells displayed abun-
dant FLPs, while the nonaggressive D2.0R and D2.1 cells failed
to do so; this mirrored the in vivo behaviors of these various cell
types in the lung parenchyma (Shibue et al., 2012; Figures S1A
and S1B).
In order to identify themechanistic basis of differing FLP abun-
dance observed in the MoT cultures, we tested the kinetics of
FLP assembly and disassembly by time-lapse imaging. We
found that the rate of de novo FLP formation was not noticeably
different among these three D2 cell types (Figure 1A). In contrast,
they exhibited a profound difference in the lifetime of FLPs: more
than 60% of FLPs observed in the aggressive D2A1 cells per-
sisted for more than 6 hr, while the majority (>75%) of FLPs
formed in the nonaggressive D2.0R and D2.1 cells persisted
less than 90 min (Figure 1A; Movies S1, S2, and S3). This indi-
cated that the difference in FLP abundance between these cell
types could be attributed largely to the differing lifetimes of FLPs.
We proceeded to identify the molecular machinery governing
FLP lifetime. In previous work, we found that the FLPs formed
by the aggressive D2A1 cells in MoT culture displayed the b1(D) Role of ILK/b-parvin in FLP formation. The numbers of FLPs per cell were p
overexpression of a-parvin were propagated in MoT cultures and stained with
expression of b-parvin and ILK, but not the overexpression of a-parvin, reduced F
has a critical effect on FLP abundance. (*), p < 0.01 versus sh scrambled/mock.
(E) Contribution of b-parvin to the extended FLP lifetime. The D2A1 cells manipul
0.002 by log-rank test versus sh scrambled. (ns), p > 0.1.
(F) Persistence of FLPs formed by human breast cancer cells. Various human b
microscopy for FLP persistence and the rate of de novo FLP formation.
(G) b-parvin-dependent FLP formation in variousmetastatic cell types. Threemeta
0.01 versus sh scrambled/mock.
Values are means ± SD (n = 3 in B) or means ± SEM (nz 20 in A, E, and F; n =
See also Figure S1 and Movies S1, S2, S3, S4, and S5.
Csubunit of integrins along the lengths of their shafts (Shibue
et al., 2012). We also noted that others had demonstrated the
critical role of integrin-ECM ligation in controlling local actin dy-
namics (Geiger et al., 2001). Together, these observations led us
to speculate that the engagement of b1-subunit-containing in-
tegrins with their ECM ligands along the lengths of FLP shafts
governs the persistence of actin fibers that structurally support
FLPs, thereby controlling FLP lifetime. Consistent with this spec-
ulation, the knockdown of integrin b1 expression in the D2A1
cells significantly reduced the lifetime, as well as the steady-
state numbers, of FLPs formed by these cells (Figure S1C). In
contrast, the knockdown of integrin b1 expression in the poorly
FLP-displaying D2.0R and D2.1 cells did not noticeably reduce
either the abundance or lifetime of FLPs (Figure S1D).
Nonetheless, the short-lived FLPs that are naturally formed by
these two indolent cell types, like those extended by the aggres-
sive D2A1 cells, harbored integrin b1 along their shafts, as
demonstrated by use of an active-conformation specific anti-
body 9EG7 (Lenter et al., 1993; Figure S1E). We concluded
that integrin b1 was actively involved in the adhesions to ECM
occurring along the shafts of FLPs in all the three types of D2
cells, regardless of the persistence time of their FLPs. It
appeared, therefore, that integrin b1-mediated adhesions
contributed critically to the prolonged lifetime of FLPs in the
aggressive D2A1 cells, doing so by increasing the persistence
of actin filaments that formed the core of these protrusions,
whereas formation of these adhesions did not appear to affect
the stability of the FLPs in the indolent D2.0R and D2.1 cells.
Based on this thinking, we examined the mechanisms con-
necting integrin b1-mediated adhesions with the actin fibers
that structurally support FLPs. In particular, we addressed the
roles of integrin:actin-linking proteins, which are thought to
govern the coordination between the integrin-mediated adhe-
sions and the control of actin organization in the vicinity of these
adhesions (Geiger et al., 2001). To begin, wemeasured the abun-
dance of messenger RNAs (mRNAs) encoding 23 known linker
proteins. Among these, the mRNA encoding b-parvin stood
out, since its levels were approximately 100-fold higher in the
aggressive D2A1 cells than in the other two indolent D2 cell
types. In contrast, none of the other 22 mRNAs surveyed ex-
hibited more than a 2.2-fold difference in expression levels in
the D2A1 cells relative to the mean expression levels in the indo-
lent D2.0R and D2.1 cells (Figure 1B).
As expected from mRNA expression, the expression of
b-parvin protein could be detected by immunoblotting only in
the aggressive D2A1 cells (Figure 1C). Moreover, the knockdown
of b-parvin expression by 87%–94% in the D2A1 cells, achievedlotted (left). D2A1 cells with knockdowns for various integrin-actin linkers or
phalloidin (F-actin; green) and DAPI (nuclei; blue) (right). Knocking down the
LP abundance. Hence, the expression level of b-parvin, but not that of a-parvin,
(ns), p > 0.3.
ated as indicated (also expressing lifeact-YPet) were analyzed as in (A). (*), p <
reast cancer cell lines (expressing lifeact-YPet) were analyzed by time-lapse
static mouse cell types were analyzed for FLP formation inMoT cultures. (*), p <
100 in D and G). Bars, 10 mm.
ancer Cell 24, 481–498, October 14, 2013 ª2013 Elsevier Inc. 483
Cancer Cell
An Integrin-Actin Link Enabling Tumor Initiationby either of two shRNAs targeting b-parvin (sh b-parvin J and L),
caused a 51%–56% decrease in FLP abundance, as well as a
significant reduction of FLP lifetime (Figures 1D and 1E; Fig-
ure S1F; Movies S4 and S5). In addition, the knockdown of the
expression of integrin-linked kinase (ILK), an essential linker
between b-parvin and integrin b chains (Yamaji et al., 2001; Fig-
ure 2A), also reduced the number of FLPs in the D2A1 cells (Fig-
ure 1D). Conversely, ectopic b-parvin expression in the more
indolent D2.0R and D2.1 cells extended FLP lifetime and
increased the steady-state number of these protrusions, an
effect that could be blunted by concomitant ILK knockdown (Fig-
ures S1F–S1H; Movies S6 and S7). Hence, the differences in the
lifetime (and, thus, abundance of FLPs observed in the various
D2 cell types) were attributable, at least in part, to the differing
expression levels of b-parvin, which appeared to control FLP life-
time in an ILK-dependent manner.
bPIX/Cdc42/PAK Axis as an Effector of ILK/b-Parvin in
Controlling FLP Formation
Given the key role played by b-parvin in the regulation of FLPs,
we sought to uncover the role of other proteins beyond ILK
that might collaborate with b-parvin in this process. In fact, in
addition to serving as a physical link between integrins and the
actin cytoskeleton, b-parvin is known to play a regulatory role
in the cytoskeleton by interacting with aPIX and bPIX (PAK-
interacting exchange factors) (Rosenberger et al., 2003). Both
PIX proteins recruit and then activate Cdc42 and Rac1 GTPases,
which, in turn, proceed to activate the Group I class of p21-
activated kinases (PAKs), i.e., PAK1-3, thereby regulating cyto-
skeletal organization (Figure 2A; Bokoch, 2003).
We therefore determined whether PIX/Cdc42(Rac)/PAK
signaling contributes to the b-parvin-dependent process of
FLP regulation. Immunoprecipitation analysis revealed that
b-parvin expressed in the aggressive D2A1 cells interacted
physically with bPIX, the only PIX isoform expressed at a detect-
able level in these cells (Figures 2B and S2F). Moreover, the
knockdown of bPIX expression (by 98% to 99%) resulted in a
46%–66% decrease in the number of FLPs formed by the
MoT-cultured D2A1 cells (Figures 2C and S2A), indicating that
b-parvin cooperates with bPIX in regulating FLP abundance.
We proceeded to examine the role of b-parvin in driving the
signaling events downstream of bPIX, namely, the sequential
activation of Cdc42 (Rac1) and PAK1-3. The knockdown of
b-parvin expression in the D2A1 cells grown in MoT culture
reduced the levels of GTP-bound, active Cdc42 and Rac1 by
70%–88% and 57%–78%, respectively (Figures 2D and S2B).
This was accompanied by the reduced phosphorylation of
PAK1 at residues critical to its kinase activity—threonine 423
(T423) within its catalytic domain as well as serines 199 and 204
(S199/204) within its autoinhibitory domain (Figure 2E). Conversely,
b-parvin overexpression in the MoT-cultured, otherwise indolent
D2.0R and D2.1 cells elevated the levels of active Cdc42 and
Rac1 and augmented phosphorylation of PAK1 on T423 and
S199/204 (Figures 2D and 2E; Figure S2B). Hence, in these D2
carcinoma cell types, b-parvin expression was both necessary
and sufficient for activating Cdc42, Rac1, and PAKs when these
cells were growing in MoT cultures.
We also compared the roles of Cdc42 and Rac1 as down-
stream effectors of the b-parvin/bPIX complex and found that484 Cancer Cell 24, 481–498, October 14, 2013 ª2013 Elsevier Inc.Cdc42 knockdown reduced both PAK1 phosphorylation and
FLP abundance far more efficiently than did Rac1 knockdown
(Figures 2E, S2C, and S2D; Shibue et al., 2012). This indicated
that Cdc42, rather than Rac1, serves as a key intermediary in
the b-parvin/bPIX-dependent PAK activation.
Finally, we tested the involvement of PAKs in FLP regulation.
The inhibition of PAK activity by overexpressing a dominant-
negative PAK1-AID fragment, which inhibits all the three of
PAK1-3 (Zhao et al., 1998), resulted in a 47% reduction in the
number of FLPs formed by the D2A1 cells in MoT culture (Fig-
ure 3A). Conversely, overexpression of a constitutively active
PAK1 mutant (PAK1 L107F) in the D2.0R and D2.1 cells
increased the number of FLPs by 3.2- and 3.0-fold, respectively
(Figure 3A). Together, these observations demonstrated the
critical role of the ILK/b-parvin/bPIX/Cdc42/PAK signaling axis
in supporting abundant FLP display (see Figure 3B).
LIMK/Cofilin Axis as a Downstream Mediator of the
Effect of PAKs on FLPs
The work described earlier did not reveal how PAKs control FLP
abundance. However, we noted that earlier studies had impli-
cated the presence of multiple effector pathways contributing
to the PAK-dependent control of cytoskeletal organization
(Bokoch, 2003; Figure 3B). Thus, PAKs activate LIM domain
kinases (LIMKs), which, in turn, inactivate the ADF/cofilin family
of proteins (i.e., ADF, cofilin1, and cofilin2; hereinafter referred
to collectively as cofilin), the central regulators of actin filament
severing. Independent of this, PAKs also impair actomyosin
contractility by inactivating myosin light-chain kinase (MLCK),
thereby reducing the phosphorylation level of the regulatory
myosin light chain (rMLC) (see Figure 2A).
We undertook to specify the role(s) of PAKs in FLP regula-
tion. In the MoT-cultured, aggressive D2A1 cells, the inhibition
of PAK activity, achieved either by b-parvin knockdown or by
PAK1-AID overexpression, impaired the phosphorylation of
cofilin1 on serine 3 (S3), an inhibitory modification usually
catalyzed by the PAK-effector LIMKs (Yang et al., 1998; Fig-
ure 2F). In contrast, neither of these manipulations noticeably
affected rMLC phosphorylation on serine 19, which is cata-
lyzed by another PAK-effector, MLCK (Figure 2F). Hence,
between the two effector pathways of PAKs (Figure 2A), the
LIMK/cofilin pathway, but not the MLCK/rMLC pathway, was
controlled by the ILK/b-parvin/bPIX/Cdc42/PAK signaling in
these cells.
Consistent with this notion, FLP formation in the MoT-cultured
D2A1 cells was impaired by overexpression of a constitutively
active cofilin1 mutant (cofilin1 S3A; Moriyama et al., 1996; Fig-
ure 3A). Moreover, the overexpression of either b-parvin or the
constitutively active mutant of either PAK1 or LIMK1 (PAK1
L107F and LIMK1-Kd3, respectively) enabled the nonaggressive
D2.1 cells to extend far more FLPs (a 2.4- to 2.7-fold increase in
FLP number), while failing to do so when the constitutively active
cofilin1 S3A mutant was expressed concomitantly (Figure 3C).
Collectively, these observations indicated that ILK/b-parvin/
bPIX/Cdc42/PAK signaling contributes to the display of abun-
dant FLPs largely, if not entirely, by causing LIMK-dependent
cofilin inactivation, which protects the actin spine of FLPs from
cofilin-mediated cleavage, thereby resulting in the increased
persistence of FLPs (Figure 3B).
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Figure 2. ILK/b-Parvin/bPIX/Cdc42/PAK/LIMK/Cofilin Signaling in FLP Formation
(A) Integrin-actin coupling by ILK/a-parvin and ILK/b-parvin complexes. a-parvin and b-parvin bind to ILK, each providing a link between integrins and actin
cytoskeleton while having different effects on cell behaviors.
(B) b-parvin/bPIX interactions. Lysates from FLAG-b-parvin-, FLAG-a-parvin- or FLAG-bPIX-expressing cells were subjected to anti-FLAG immunoprecipitation
and analyzed by immunoblotting. bPIX interacts with b-parvin but not with a-parvin. Asterisk indicates nonspecific bands.
(C) Role of bPIX in FLP regulation. Knocking down the expression of bPIX, but not that of dysferlin (a transmembrane protein that interacts with b-parvin; Matsuda
et al., 2005), reduced FLP abundance in the D2A1 cells. Values are means ± SEM (n = 100). (*), p < 0.001. (ns), p > 0.3.
(D) b-parvin expression and Cdc42 activation. Values represent the intensities of the active Cdc42 bands relative to that of corresponding total Cdc42 band.
(E) b-parvin/Cdc42/bPIX signaling in PAK phosphorylation. Here and in (F), values represent the intensities of pPAK1 (phospho-cofilin1/phospho-rMLC) bands
relative to that of the corresponding total PAK1 (cofilin1/rMLC) band. The blots are representative of multiple independent experiments.
(F) Cofilin and rMLC phosphorylation in the downstream of b-parvin/PAK signaling.
See also Figure S2.
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Figure 3. Cooperation of Rif/mDia2 and ILK/b-Parvin/Cofilin Pathways in FLP Regulation
(A) Role of PAK/LIMK/cofilin axis in FLP regulation. Cells manipulated as indicated to alter the activity of PAK/LIMK/cofilin signaling were analyzed for FLP
formation in MoT cultures. Bar, 10 mm.
(B) Cooperation of the two signaling axes, Rif/mDia2 and ILK/b-parvin/cofilin, for abundant FLP display.
(C) Differential requirement for cofilin inactivation between Rif/mDia2 and ILK/b-parvin/cofilin signaling pathways. The control (mock) and cofilin1 S3A-expressing
D2.1 cells were further engineered to activate either of Rif/mDia2 or ILK/b-parvin/cofilin signaling pathways and analyzed for FLP formation.
(D) Requirement for basal Rif/mDia2 activity in b-parvin/PAK-driven FLP formation. The D2.1 cells with enforced activation of ILK/b-parvin/cofilin signaling were
further engineered to knockdown Rif or mDia2 expression (left), while those with enforced Rif/mDia2 activation were additionally engineered to knockdown bPIX
or to overexpress PAK1-AID (right), before the FLP formation by these cells was analyzed.
(legend continued on next page)
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An Integrin-Actin Link Enabling Tumor InitiationTwo Signaling Pathways that Cooperatively Govern FLP
Formation
The ILK/b-parvin/bPIX/Cdc42/PAK/LIMK/cofilin (hereinafter
referred to as ‘‘ILK/b-parvin/cofilin’’) signaling axis characterized
earlier was not the only determinant of FLP abundance. In earlier
work, we had uncovered the essential contribution of the Rif/
mDia2 actin-nucleating/polymerizing machinery to FLP forma-
tion (Shibue et al., 2012). Indeed, others had shown that Rif
and mDia2 cooperatively induce the nucleation of actin mono-
mers and subsequent elongation of actin filaments (Mellor,
2010), which constitute the structural core of FLPs. These earlier
observations, together with the presently demonstrated contri-
bution of cofilin-inactivating signaling pathway to FLP abun-
dance, suggested that there are actually two distinct signaling
pathways—Rif/mDia2 signaling on the one hand and ILK/
b-parvin/cofilin signaling on the other—that collaborate in the
induction and maintenance of FLPs (Figure 3B). Thus, the first
pathway causes the formation of actin fibers that drives the initial
extension of FLPs, while the second pathway ensures the stabi-
lization of these FLPs once they are formed.
We undertook to study in detail the cooperative actions of
these two signaling axes. We found that changes in FLP abun-
dance induced by the enforced activation of Rif/mDia2 signaling
were not associated with noticeable alterations in the cofilin1
phosphorylation on S3, the site critical to the regulation of cofilin1
activity (Figures 2F and 3C). This contrasted sharply with the
regulation of FLPs by ILK/b-parvin/cofilin signaling, which
involved and depended critically on changes in cofilin activity
(Figures 2F and 3C). Together, these observations indicated
the independent, complementary actions of these two signaling
pathways in regulating FLP abundance (Figure 3B).
We also analyzed the effect of simultaneously manipulating
both pathways. Here, we found that the enhanced display of
FLPs in the naturally poorly FLP-forming D2.1 cells, which could
be achieved by the enforced activation of ILK/b-parvin/cofilin
signaling, was reversed by the concomitant knockdown of either
Rif or mDia2 expression (Figure 3D). This indicated that the tonic
activity of Rif/mDia2 signaling is naturally maintained in the D2.1
cells and suggested that the inability of these cells to display
abundant FLPs could be ascribed largely to their ineffective acti-
vation of ILK/b-parvin/cofilin signaling, which resulted, in turn,
from their failure to synthesize significant levels of b-parvin pro-
tein (Figure 1C).
We proceeded further to examine the kinetics of FLP assembly
and disassembly by time-lapse imaging. Consistent with the
effects of b-parvin in extending the lifetime of FLPs (Figures 1E
and S1G), inhibition of ILK/b-parvin/cofilin signaling in the
aggressive D2A1 cells, achieved by the expression of either
dominant-negative PAK1-AID fragment or constitutively active
cofilin1 S3A mutant, reduced the persistence period of FLPs,
while the enforced activation of this signaling in the indolent
D2.1 cells increased this persistence (Figures 3E and 3F). How-
ever, none of these manipulations noticeably affected the rate of(E and F) Effects of signaling manipulation on FLP dynamics. D2A1 (E) and D2.1
formation, respectively, and analyzed by time-lapse microscopy.
Values are means ± SEM (n = 100 in A, C, and D; nz 20 in E and F). (*), p < 0.00
(by Student’s t test).
See also Figure S3 and Movies S6, S7, and S8.
Cde novo FLP formation. In contrast, the enforced elevation of
Rif/mDia2 signaling activity in the indolent D2.1 cells resulted
in a significant (R1.9-fold) increase in the rate of FLP initiation
and a modest extension of FLP lifetime (Figure 3F; Movies S6
and S8).
These observations reinforced the notion that Rif/mDia2
signaling contributes primarily to the de novo formation of
FLPs by stimulating the nucleation/polymerization of the actin
fibers that structurally support FLPs, while ILK/b-parvin/cofilin
signaling specifically helps tomaintain the resulting FLPs by sup-
pressing the cofilin-dependent cleavage of such actin fibers.
Together, these two signaling collaborate to enable cells to
display large numbers of FLPs (see Figure 3B).
ILK/b-Parvin/Cofilin Signaling and In Vitro Cell Behavior
As mentioned earlier, we had found that the formation of FLPs
contributes to the assembly of integrin b1-containing, mature
adhesion plaques of elongated morphology in cells grown in
MoT culture, doing so by fostering the nucleation of protein
complexes that constitute the core of these plaques (Figure 4A;
Shibue et al., 2012). Consistent with this earlier observation, the
inhibition of ILK/b-parvin/cofilin signaling—the signaling axis
critical to the extended lifetime and, thus, to the display of abun-
dant FLPs—reduced the number of integrin b1-containing adhe-
sion plaques in the D2A1 cells growing in MoT culture (Figures
4B and S4A). In addition, the inhibition of ILK/b-parvin/cofilin
signaling reduced the levels of activation-associated phosphor-
ylation of FAK and ERKs and attenuated proliferation when the
D2A1 cells were growing under MoT culture conditions, while
not noticeably affecting their proliferation in monolayer culture
(Figures 4C–4E and S4B–S4D). This reinforced the role of FLP
formation as a critical trigger for the establishment of cell-matrix
adhesions and rapid cell proliferation in cells grown in MoT cul-
ture (see Figure 4A).
We proceeded to test whether the contribution of ILK/
b-parvin/cofilin signaling to these processes was generalizable
to other cancer cell types. In fact, our previous work had demon-
strated that, among 18 different lines of human breast cancer
cells, those that were competent to form metastatic colonies
developed far more abundant FLPs than did their colonization-
deficient counterparts (Shibue et al., 2012). The subsequently
pursued time-lapse observations of such cells growing in MoT
culture revealed that the FLPs formed in the colonization-
competent BT549, MDA-MB-231, and SUM1315 cells persisted
far longer than those extended by the colonization-deficient
BT474, SK-BR-3, T47D, and ZR-75-1 cells (Figure 1F). Consis-
tently, these three colonization-competent cell types exhibited
elevated activity of the FLP-stabilizing ILK/b-parvin/cofilin
signaling, as determined by examining the levels of cofilin1 phos-
phorylation on S3—the endpoint of this signaling pathway (see
Figure 3B)—relative to the four colonization-deficient cell
types tested here (Figures S2E and S2F). Together, these obser-
vations supported the notion that the display of abundant FLPs,(F) cells (expressing lifeact-YPet) were engineered to block and stimulate FLP
01. (**), p < 0.05. (***), p < 0.0001 (versus mock; by log-rank test). (ns), p > 0.2
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Figure 4. In Vitro Effects of ILK/b-Parvin/Cofilin Signaling Manipulation
(A) Cell-biological and biochemical events that drive cell proliferation in MoT culture and within the lung parenchyma.
(B and C) Role of ILK/b-parvin/cofilin signaling in adhesion plaque assembly and proliferation. The D2A1 cells were manipulated as indicated, with which the rates
of mature adhesion plaque assembly in MoT cultures (B) and the cell numbers after 10 days of monolayer or MoT cultures (C) were determined. Bar, 10 mm.
(D and E) b-parvin/PAK signaling and FAK/ERK activation. Values represent the intensities of pFAK (pERK) bands relative to that of the corresponding total FAK
(ERK) band.
(F) ILK/b-parvin/cofilin signaling and proliferation in various cell types. Indicated cell types weremanipulated to block ILK/b-parvin/cofilin signaling, with which the
cell numbers after 10 (15 for MDA-MB-231) days of monolayer/MoT cultures were determined.
Values are means ± SD (n = 3) in (B), (C), and (F). (*), p < 0.02. (ns), p > 0.1 versus sh scrambled/mock.
See also Figure S4.
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An Integrin-Actin Link Enabling Tumor Initiationobserved specifically in the colonization-competent cells, is
attributable, in part, to the elevated activity of the ILK/b-parvin/
cofilin signaling and the resulting prolonged lifetime of FLPs.
We also blocked the activity of ILK/b-parvin/cofilin signaling in
the colonization-competent SUM159 and MDA-MB-231 human
breast cancer cells. This resulted in impaired FLP formation
and reduced proliferation rate in MoT cultures while minimally
affecting their proliferation in monolayer cultures (Figures 4F
and S3A). Hence, ILK/b-parvin/cofilin signaling contributed crit-
ically to the abundant FLP display and rapid cell proliferation in
the 3D MoT cultures of multiple colonization-competent carci-
noma cell types.
ILK/b-Parvin/Cofilin Signaling and Metastatic
Aggressiveness In Vivo
The MoT culture used in the experiments cited earlier was
designed to approximate the microenvironment surrounding
cancer cells that have recently extravasated into the lung paren-
chyma (Barkan et al., 2008; Shibue and Weinberg, 2009). We
wanted to extend the findings of these experiments by deter-
mining whether the ILK/b-parvin/cofilin signaling axis also regu-
lates metastatic cell behaviors in the lungs. In fact, various
strategies to block this signaling pathway all reduced (by 2.3-
to 9.0-fold) the number of macroscopic lung metastases formed
24 days after the tail-vein injection of the D2A1 cells; this was
associated with impaired proliferation within the lung tissue as
measured 7 days after the injection (Figure 5A; Figure S5A). In
contrast, none of these manipulations noticeably affected
D2A1 cell proliferation in monolayer culture (Figure 4C).
We also examined in detail lung sections prepared 10 days
after tail-vein injection of the D2A1 cells. Here again, the inhibi-
tion of ILK/b-parvin/cofilin signaling in the D2A1 cells decreased
(2.3- to 4.1-fold) the numbers of large metastatic colonies (those
with >20 cells per colony), while the numbers of small colonies
(%20 cells per colony), which consisted largely of viable but
nonproliferative cells, were actually increased (1.3- to 2.4-fold;
Figures 5B and S5B). This echoed the previously observed
effect of knocking down Rif or mDia2 expression in the D2A1
cells (Shibue et al., 2012). Together, these observations led
us to conclude that blocking FLP formation in the recently
extravasated D2A1 cells constrains these cells to reside in the
lung parenchyma as viable, weakly proliferating micrometastatic
cells.
We undertook to analyze how the inhibition of ILK/b-parvin/
cofilin signaling affects the initial steps of extravasation and
postextravasation processes of metastasis. In fact, the blockade
of this signaling axis in the aggressive D2A1 cells did not notice-
ably affect the efficiency of extravasation into the lung paren-
chyma while being effective in reducing the abundance of
FLPs and mature adhesion plaques formed by the extravasated
cells; this was accompanied by a reduced level of FAK activation
relative to that of the control cells (Figures 5C, 5D, and S5C–
S5E). Hence, the action of ILK/b-parvin/cofilin signaling was crit-
ical, following extravasation into the lung parenchyma, to the
FLP-dependent establishment of productive cell-matrix interac-
tions by the D2A1 cells, which, in turn, governed their subse-
quent proliferation (see Figure 4A).
We askedwhether other types of colonization-competent cells
also depend on the activity of ILK/b-parvin/cofilin signaling inCorder to colonize the lung tissue. Accordingly, we tested
three colonization-competent mouse cell types, namely, TS/A
mammary carcinoma cells, B16F10 melanoma cells, and
TRAMP-C2 prostate cancer cells, all of which exhibited b-parvin-
dependent FLP formation in MoT cultures (Figures 1G and S1I).
We found that, in all three cases, the knockdown of b-parvin
expression reduced the number of macroscopic lung metasta-
ses formed after tail-vein injection (Figures 5E and S5F). Simi-
larly, blockade of ILK/b-parvin/cofilin signaling in the human
breast cancer cell lines SUM159 and MDA-MB-231 also
impaired formation of lung macrometastases by these cells (Fig-
ure 5F). Notably, none of these manipulations discernibly
affected the proliferation of these cells in monolayer cultures
(Figures 4F and S4E). These observations confirmed the role of
ILK/b-parvin/cofilin signaling as a critical controller of metastatic
aggressiveness in multiple cancer cell types.
FLP Formation and Tumorigenicity of Orthotopically
Implanted Cells
These various observations caused us to test the involvement of
ILK/b-parvin/cofilin signaling in earlier steps of experimental
tumor formation. Thus, we speculated that the adaptations that
experimentally implanted cancer cells must initially undergo in
sites of engraftment resemble those that are required for the
establishment of disseminated cancer cells as founders in sites
of metastatic colonization. Based on this thinking, we implanted
various cancer cell types into either orthotopic (mammary fat
pads in the case of mammary carcinomas) or ectopic subcu-
taneous sites in murine hosts, doing so with or without manipu-
lating these cells by blocking ILK/b-parvin/cofilin signaling. This
revealed that some of these manipulations reduced the inci-
dence of primary tumor formation: for example, the knockdown
of bPIX expression reduced tumor incidence following the
implantation of the D2A1 cells in the mammary fat pad from
96% to 42%–64% (Figures S6A–S6C). This echoed our previous
observation that inhibition of Rif/mDia2 signaling in the D2A1
cells reduced the rate of primary tumor formation after the ortho-
topic implantation (Shibue et al., 2012). Together, these observa-
tions suggested that the ability of cells to display abundant FLPs
contributes to the establishment of primary tumors at sites of
implantation.
We pursued these effects further by measuring tumor-initi-
ating frequency of two cancer cell types, namely, D2A1 and
MDA-MB-231 cells, after implanting them at limiting dilutions.
We found that blocking FLP formation, achieved by inhibiting
either the Rif/mDia2 or the ILK/b-parvin/cofilin pathway, signifi-
cantly reduced the estimated frequency of tumor-initiating cells
(TICs) in both cell populations (Figure 6A; Figure S6D). This led
us speculate that the formation of FLPs, which enables rapid
proliferation of cancer cells following extravasation into the
lung parenchyma (see Figure 4A), also governs the initial prolifer-
ation of cancer cells at sites of implantation, thereby critically
affecting the efficiency with which these cells establish primary
tumors in host mice.
Indeed, shortly after implantation into mammary fat pads, the
D2A1 cells displayed FLPs, which resembled those formed by
these cells following extravasation into the lung parenchyma
(Figures 6B and 6C). Moreover, the number of FLPs formed
2 days after the implantation of the D2A1 cells was decreasedancer Cell 24, 481–498, October 14, 2013 ª2013 Elsevier Inc. 489
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pathway, whichwas accompanied by the significant reduction of
the proliferation rate that was measured 3 days later (Figures 6D
and 6E). Hence, the cooperative actions of Rif/mDia2 and ILK/
b-parvin/cofilin signaling pathways and the resulting, abundant
formation of FLPs (see Figure 3B) contributed critically to the
active proliferation of recently implanted D2A1 cells within mam-
mary fat pads.
We also found that both Rif- and b-parvin-knockdown
impaired FAK activation in the orthotopically implanted D2A1
cells (Figure 6F). This attenuation of FAK signaling was likely to
account for the reduced TIC frequency caused by these knock-
downs, since the concomitant expression of the constitutively
active CD2-FAK fusion protein partially restored this frequency
(Figure 6G). In addition, the knockdown of FAK expression
impaired ERK activation in the mammary fat-pad-implanted
D2A1 cells (Figure 6F). Together, these observations indicated
that the proliferation of the recently implanted cancer cells in
the mammary fat pads is governed, in part, by the mechanisms
involving FLP extension and the resulting activation of FAK/ERK
signaling, which mirrored the regulation on the proliferation of
recently extravasated cancer cells in the lungs (see Figure 4A).
Correlation between ILK/b-Parvin/Cofilin Signaling
Activity and Tumorigenic Potential
We examined in greater detail the behavior of the D2A1 cells that
had been recently implanted into the mammary fat pads. This
revealed that the numbers of FLPs formed by the individual cells
within the D2A1 cell population were highly variable from one
cell to another (Figure S6E), which led us to speculate that the
cells displaying more abundant FLPs had a higher tumor-
initiating potential, i.e., an ability to seed tumors in host mice
following implantation, than did those forming only small
numbers of these protrusions. To test this, we fractionated the
D2A1 cells into different subpopulations in order to examine
whether the FLP-forming ability of the cells in these various sub-
populations correlated with their content of TICs.
Others have separated mouse mammary carcinoma cells
based on the expression of CD29 and CD24 cell surfacemarkers
and found that the subpopulation of cells with CD29high/CD24high
(29H/24H) profile exhibited a significant enrichment of TICs
(Zhang et al., 2008). Consistent with this observation, we noted
that the 29H/24H fraction of the D2A1 cells exhibited a TIC fre-Figure 5. In Vivo Effects of ILK/b-Parvin/Cofilin Signaling Manipulation
(A and B) ILK/b-parvin/cofilin signaling and metastatic colonization. The D2A1 c
membrane in (B)—were manipulated as indicated and tail-vein injected. In (A), r
24 days after injection, as well as the phospho-histone H3 positivity of the cells res
and (F), the red bar represents the mean value within each sample group. In (B)
quantified on the lung sections prepared 10 days after injection. M, large metast
(C and D) b-parvin/PAK axis and in vivo cell-matrix adhesions. In (C), the D2A1
engineered as indicated, were tail-vein injected. FLP formation was analyzed on
33342; blue) were also visualized (left and middle). The formation of elongated a
fusion protein instead of lifeact-Tag-RFP-T (right). In (D), the D2A1 cells engineere
FAK-HA was immunoprecipitated from the lung lysate and analyzed by immuno
(E and F) Role of ILK/b-parvin/cofilin signaling in lung colonization by various cell
MB-231 cells, also expressing GFP (E) or tdTomato (F), were tail-vein injected, a
Values are means ± SD (n = 3 in (A, middle), (B), and (C, right)] and means ± SEM (
(*), p < 0.005. (**), p < 0.05. (ns), p > 0.05 versus sh scrambled/mock.
See also Figure S5.
Cquency 4.1- and 27-fold higher than that of theCD29high/CD24low
(29H/24L) and CD29low (29L) groups, respectively (Figures 7A
and 7B).We also found that cells of the aggressive 29H/24H sub-
population extended a larger number of FLPs than did the cells
of the other two subpopulations both in MoT culture and within
the mammary fat pads (Figures 7C, 7D, and S7A). Hence, the
observed difference in the TIC frequency of these various
D2A1 cell subpopulations correlated with the FLP-forming abili-
ties of their constituent cells.
Wishing to extend these observations to other cell types, we
studied the HMLER transformed human mammary epithelial
cells (Elenbaas et al., 2001). As reported previously, these
HMLER cells can be sorted, according to the expression profile
of the CD44 and CD24 markers, into two subpopulations: a TIC-
enriched CD44high/CD24low (44H/24L) subpopulation and a
TIC-depleted CD44low/CD24high (44L/24H) subpopulation (Mani
et al., 2008; Figure 7E). When propagated in MoT culture, cells
of the 44H/24L subpopulation displayed a far larger (13.43)
number of FLPs than did cells of the 44L/24H subpopulation
(Figure 7F). Hence, in both the D2A1 and HMLER cultures, the
cells from the TIC-enriched subpopulations extended FLPs
more abundantly than did the cells from the TIC-depleted
subpopulations.
We undertook to identify the determinants of differing FLP
abundance between the cells of these various subpopulations.
Time-lapse observation of these cells growing in the MoT culture
revealed that FLPs formed by cells of the TIC-enriched subpop-
ulations (i.e., 29H/24H in the D2A1 cells and 44H/24L in the
HMLER cells) exhibited a significantly longer lifetime than those
extending from cells of the corresponding other subpopulations
(Figures S7C and S7D). Consistent with this observation, cells
of these TIC-enriched subpopulations exhibited a higher level
of the cofilin1-inactivating S3 phosphorylation—the endpoint of
the signaling pathway that governs FLP lifetime, i.e., ILK/
b-parvin/cofilin signaling (see Figure 3B)—than did the cells of
the other subpopulations (Figure 7G). Moreover, FLP formation
by cells of the HMLER 44H/24L subpopulation was impaired
by expressing the constitutively active cofilin1 S3A mutant in
these cells, which ultimately reduced the TIC frequency in this
subpopulation (Figures 7H, S7E, and S7F). Collectively, these
various observations supported the notion that the elevated
TIC frequency—observed in the 29H/24H subpopulation of
the D2A1 cells and the 44H/24L subpopulation of the HMLERells expressing fluorescent markers—GFP or tdTomato in (A) and tdTomato-
epresentative lung images (left) and the numbers of macrometastases (right)
iding in the lungs 7 days after injection (middle), were presented. Here and in (E)
, relative numbers of small (%20 cells) and large metastases (>20 cells) were
ases.
cells expressing integrin a5-YPet (green) and lifeact-Tag-RFP-T (red), further
the lung sections, where blood vessels (PECAM-1; white) and nuclei (Hoechst
dhesion plaques was scored similarly, except for using a-actinin-Tag-RFP-T
d as indicated, also expressing FAK-HA, were tail-vein injected. Five days later,
blotting.
types. The control and manipulated B16F10, TRAMP-C2, SUM159, and MDA-
nd subsequent formation of lung metastases was analyzed.
n = 150 in C, left). Bars, 2 mm in (A), (E), and (F); 100 mm in (B); and 10 mm in (C).
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An Integrin-Actin Link Enabling Tumor Initiationcells—is attributable, in part, to the enhanced FLP-stabilizing
ability of their constituent cells, which results, in turn, from
the elevated activity in these cells of the ILK/b-parvin/cofilin
signaling.
ILK/b-Parvin/Cofilin Signaling and the Process of
Epithelial-Mesenchymal Transition
Cancer cells can often develop a higher tumor-initiating potential
during the course of tumor progression (Pece et al., 2010). In the
case of carcinomas, this acquisition of malignant phenotypes is
often achieved by the passage through the cell-biological pro-
gram termed the epithelial-mesenchymal transition (EMT); more-
over, as demonstrated previously, the forced induction of an
EMT in cancer cells endows them with a greatly increased
tumor-initiating potential (Mani et al., 2008; Morel et al., 2008).
These earlier observations, together with our present demon-
stration of the critical role of FLPs in the process of tumor initia-
tion, prompted us to ask whether the EMT-dependent induction
of the tumor-initiating potential involves and depends on the
enhancement of FLP formation. Accordingly, we ectopically ex-
pressed the Twist transcription factor, an inducer of the EMT
program (Yang et al., 2004), in the naturally epithelial HMLER
cells (Figures 8A and 8B; Figure S8A). Consistent with previous
observations (Mani et al., 2008), Twist-induced EMT in these
cells was accompanied by an enhanced tumor-initiating poten-
tial in the mammary fat pads (a 132-fold increase in TIC
frequency) and an increased power of metastasis formation
(Figures 8C and 8D).
Of relevance here, Twist-induced EMT in the HMLER cells
stimulated their FLP-forming ability both in MoT culture and
following orthotopic implantation, which was accompanied by
marked increases in the expression levels of multiple compo-
nents of the ILK/b-parvin/cofilin signaling, namely ILK (4.73),
b-parvin (13.63), and LIMK1 (3.23) (Figures 8B, 8E, and 8F).
Moreover, both the elevated expression of these three compo-
nents of the ILK/b-parvin/cofilin signaling pathway and the
enhanced display of FLPs were reproduced by other strategies
of EMT induction, specifically, the overexpression of Snail tran-
scription factor and the knockdown of E-cadherin adhesion pro-
tein (Figures 8B and 8E).
We proceeded to examine the functional role of the elevated
b-parvin expression on the behavior of Twist-expressing HMLER
cells. This revealed that the knockdown of b-parvin expression
partially reversed multiple properties conferred on these cellsFigure 6. FLP Formation and Tumorigenesis of Experimentally Implan
(A) Role of FLP-regulating proteins in primary tumor formation. The D2A1 cells we
eight days later, the formation of palpable tumors was scored, from which TIC fr
(B and C) FLPs and elongated adhesion plaques formed by the mammary fat-pad
of the lifeact-Tag-RFP-T (red in B) or a-actinin-Tag-RFP-T (red in C) were implante
in B) and elongated adhesion plaques (pink arrowheads in C) was analyzed on th
(D and E) Effect of blocking FLP formation in the mammary fat-pad-implanted cell
indicated, were mixed and implanted to analyze FLP formation within the mamm
Proliferation and apoptosis of implanted cells were analyzed by staining the sect
(F) FAK/ERK activation in the mammary fat-pad-implanted cells. The D2A1 ce
indicated and implanted. Subsequently, FAK-HA or FLAG-ERK1 was immunopre
(G) Restoring tumor-initiating ability by enforced FAK activation. The D2A1 ce
constitutively active CD2-FAK. Primary tumor formation by these and the contro
Values are means ± SEM (n = 100 in B and D) and means ± SD (n = 3 in C and E
See also Figure S6.
Cby the expression of Twist, including increased FLP abundance
and elevated phosphorylation levels of PAK1 (on T423 and
S199/204) and cofilin1 (on S3), all of which were observed in MoT
culture (Figures 8B, 8E, 8F, and S8B). Moreover, b-parvin knock-
down also reduced the aggressiveness of HMLER-Twist cells
in vivo: both tumor initiation and metastasis formation were
impaired significantly by this knockdown (Figures 8C and 8D).
We concluded that the elevated tumor-initiating and metas-
tasis-forming powers imparted to the HMLER cells by Twist-
induced EMT, and presumably by the EMTs induced by other
strategies, depended on enhanced FLP display; this was
enabled, in turn, by the elevated expression levels of several
components of ILK/b-parvin/cofilin signaling pathway, including
b-parvin.
We also tested whether the connection between FLP forma-
tion and EMT process could be extended to other cell types.
Accordingly, we induced a mesenchymal-epithelial transition
(MET)—the reverse process of an EMT—in the naturally
mesenchymal D2A1 cells, doing so by the combination of Snail
knockdown and E-cadherin overexpression (Figures 8B and
S8C–S8F). As anticipated, the D2A1 cells that underwent an
MET exhibited a profound loss of tumor-initiating and metas-
tasis-forming powers (Figures 8C and 8D). Moreover, this MET
induction was associated with the 2.7-fold decrease in the
number of FLPs formed by these cells in MoT culture (Fig-
ure S8G). In addition, the D2A1 cells that underwent an MET
also exhibited decreased expression of several components
of the ILK/b-parvin/cofilin signaling pathway—namely, ILK,
b-parvin, and LIMK1—all of which contrasted to the effects of
EMT in the HMLER cells (Figures 8B and S8H). Hence, in both
HMLER cells and the D2A1 cells, the transition between the
epithelial and mesenchymal states involved changes in the
expression levels of multiple components of the ILK/b-parvin/
cofilin signaling pathway. This altered, in turn, their ability to
form FLPs and ultimately contributed to changes in tumor-
initiating and metastasis-forming powers exhibited by the cells
undergoing this cell state transition.
DISCUSSION
While the role of integrin-mediated cell-matrix adhesions in
enabling the outgrowth of metastases had been recognized
(Aguirre Ghiso et al., 1999; Barkan et al., 2008), the manner
by which extravasated cancer cells interact with the ECMted Cells
re engineered as indicated and implanted into the mammary fat pads. Twenty-
equency was calculated.
-implanted cells. The D2A1 cells expressing integrin a5-YPet (green) and either
d together with nonlabeled D2A1 cells. The formation of FLPs (blue arrowheads
e sections of the fat pads.
s. In (D), fluorescent-labeled and nonlabeled D2A1 cells, further manipulated as
ary fat pads. In (E), D2A1 cells were engineered as indicated and implanted.
ions of the fat pads for Ki67 (red) and cleaved caspase-3 (green), respectively.
lls expressing either of FAK-HA or FLAG-ERK1 were further manipulated as
cipitated from the lysate of the fat pads and analyzed.
lls with Rif or b-parvin knockdown were further manipulated to express the
l cells was analyzed.
). Bars, 10 mm in (B) through (D) and 100 mm in (E). (*), p < 0.01, (ns), p > 0.1.
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An Integrin-Actin Link Enabling Tumor Initiationcomponents of the parenchyma of their host tissue remained to
be elucidated. We previously reported that the ability of cancer
cells to form abundant FLPs following extravasation into the
parenchyma of foreign tissues contributes critically to the estab-
lishment by these cells of productive interactions with the ECM
of their host tissue (Shibue et al., 2012). We also demonstrated
the essential role of Rif/mDia2 actin-nucleating/polymerizing
machinery in the formation of FLPs. Here, we have described
two findings that together provide an important extension to
our understanding of the role of FLPs in controlling cancer cell
behaviors.
To begin, we identified a signaling mechanism that yields an
extended lifetime of FLPs and thereby contributes to the abun-
dance of these protrusions in the colonization-competent cancer
cells. Thus, the activation of the ILK/b-parvin/cofilin signaling
axis at sites of FLP formation enables the persistence of these
protrusions once they are assembled. As is the case with the
Rif/mDia2 signaling (Shibue et al., 2012), the action of ILK/
b-parvin/cofilin signaling is critical to the metastatic colony-
forming ability of multiple aggressive cancer cell types.
Of note, the enforced activation of this signaling pathway, on
its own, does not always suffice to confer metastatic powers
on otherwise indolent cancer cells. For example, in the nonag-
gressive D2.1 cells, which do not express b-parvin at a detect-
able level, ectopic b-parvin expression sufficed to enable these
cells to display abundant FLPs in MoT culture. However, these
b-parvin-expressing D2.1 cells did not subsequently succeed
in developing mature adhesion plaques and in proliferating
rapidly under the MoT conditions, nor did they form a large num-
ber of macroscopic metastases in the lungs following tail-vein
injection (Figure S3). Hence, these D2.1 cells appeared to suffer
at least one additional defect beyond the lack of b-parvin expres-
sion that precluded their aggressive behavior both inMoT culture
in vitro and within the lung parenchyma in vivo.
While this was not addressed directly by the present work, we
suggest that the dynamics of FLP formation and the contribution
of FLPs to metastatic outgrowth will prove to be relevant to the
colonization process of various target tissues. Indeed, we previ-
ously demonstrated that blocking FLP formation by Rif knock-
down in the B16F10 melanoma cells diminishes the ability of
these cells to colonize multiple organs, such as the lungs, liver,
and bonemarrow, following intracardiac injection into syngeneicFigure 7. Display of Abundant FLPs by Cells of the TIC-Enriched Subp
(A) Sorting of the D2A1 cells by CD29/CD24 expression. The cells of each subp
mation (right).
(B) Tumor sphere formation by the sorted D2A1 cells. Cells were sequentially pass
the second round of culture are presented (top).The numbers of tumorspheres a
(C and D) Formation of FLPs and elongated adhesion plaques by the sorted D2A1
elongated adhesion plaque formation. In D, the D2A1 cells that did and did not ex
implanted. The formation of FLPs (gray arrowheads) by these cells was analyzed
(E) Sorting of the HMLER cells by CD44/CD24 expression.
(F) Formation of FLPs and elongated adhesion plaques by the sorted HMLER ce
(G) Expression of FLP-regulating proteins in cells of the various D2A1 and HML
cultures and analyzed by immunoblotting.
(H) Blocking ILK/b-parvin/cofilin signaling in the 44H/24L subpopulation of HMLE
S3A. These and the control cells were sorted, and the 44H/24L subpopulation o
Values are means ± SD (n = 3 in B, C right, and F right) andmeans ± SEM (n = 100 i
(**), p < 0.02.
See also Figure S7.
Cmice (Shibue et al., 2012). This prompts us to suggest that FLP
formation and resulting establishment of productive cell-matrix
interactions represent a common prerequisite to the metastatic
colonization of many types of target organs.
The second lesson of the present study relates to the role of
FLPs in the establishment of primary tumors by experimentally
implanted cancer cells. Thus, as shown here, multiple cancer
cell types depend on the FLP-regulating signaling pathways for
efficiently establishing primary tumors following experimental
implantation in murine hosts. In support of this finding, we also
presented examples where the increased tumor-initiating poten-
tial of cancer cells was correlated closely with their enhanced
ability of FLP formation. More specifically, cells of the TIC-
enriched subpopulations of both D2A1 and HMLER cells dis-
played FLPs far more abundantly than the remaining cells in
these populations.
Recent studies have revealed that many types of solid tumors
contain both cells that can efficiently seed tumors upon trans-
plantation into mice and those that are unable to do so; these
are often referred to as cancer stem cells (CSCs) and nonstem
cancer cells (non-CSCs), respectively (Clevers, 2011). The effi-
cient tumor seeding by many, if not all, types of carcinoma
CSCs is likely to be supported by the EMT program. Indeed,
the induction of EMT suffices to confer on cancer cells not only
an increased tumor-initiating potential but also many other attri-
butes of CSCs, including enhanced resistance to chemothera-
peutic agents and a slower rate of proliferation (Gupta et al.,
2009). However, the specific mechanism(s) by which the EMT
program potentiates the tumor-initiating powers of carcinoma
cells has remained elusive. The present observations point to
the contribution of the EMT program to increasing the expres-
sion of proteins that are critical for FLP formation and to the
role of FLP formation in governing tumor-initiating potential.
Together, they provide a mechanistic explanation of how the
EMT program can contribute to the elevated tumor-initiating
ability of CSCs.
To summarize, we propose that in certain, and perhaps many,
types of cancer cells, their initial proliferation following both
experimental implantation and metastatic dissemination is
governed, in part, by the common regulatory mechanism
involving FLP formation and the resulting assembly of mature
adhesion plaques. Clearly, other factors, such as cytokines,opulation
opulation were implanted into mammary fad pads to score primary tumor for-
aged for the three rounds of 10-day culture. Representative images of cells after
fter each round of culture were scored (bottom).
cells. In C, sorted D2A1 cells were propagated in MoT cultures to analyze FLP/
press the fluorescent actin marker lifeact-YPet (green) were sorted, mixed, and
on the sections of the fat pads.
lls in MoT cultures.
ER subpopulations. Cells of these subpopulations were propagated in MoT
R cells. HMLER cells were manipulated to express constitutively active cofilin1
btained from each cell type was implanted to score primary tumor formation.
n C left and F left). Bars, 200 mm in (B) and 10 mm in (C), (D), and (F). (*), p < 0.005.
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Cancer Cell
An Integrin-Actin Link Enabling Tumor Initiationgrowth factors, and responsive stromal cells in the micro-
environment, must also contribute to determining the eventual
successful formation of both primary and metastatic tumors.
Nonetheless, the initial formation of FLPs, which depends criti-
cally on the Rif/mDia2 and ILK/b-parvin/cofilin signaling path-
ways, appears to constitute a key rate-limiting step that governs
both processes of tumor formation.
EXPERIMENTAL PROCEDURES
Cell Culture
The MoT culture was performed as described elsewhere (Shibue and Wein-
berg, 2009). Unless otherwise indicated, cells were propagated for 12 hr
(for FLP formation), 5 days (for adhesion and phosphorylation analyses), or
10 days (for cell number determination).
Animal Procedure
All animal experiments conformed to the Guide for the Care and Use of Labo-
ratory Animals published by the National ResearchCouncil andwere approved
by the Massachusetts Institute of Technology Committee on Animal Care.
Live-Cell Imaging
Live-cell imaging was performed on a spinning-disc confocal microscopy
system, equipped with a Nikon Eclipse TE2000 inverted microscope.
Statistical Analysis
Statistical analyses were carried out by Student’s t test, unless otherwise
indicated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, and eight movies and can be found in this article online at
http://dx.doi.org/10.1016/j.ccr.2013.08.012.
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